14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.640 $1.07 Thursday, 2nd May 2024 CTXR stock ended at $0.707. This is 2.66% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 10.29% from a day low at $0.680 to a day high of $0.750.
90 days $0.600 $1.07
52 weeks $0.600 $1.45

Historical Citius Pharmaceuticals Inc prices

Date Open High Low Close Volume
Mar 27, 2024 $0.790 $0.83 $0.780 $0.82 443 915
Mar 26, 2024 $0.82 $0.82 $0.775 $0.80 558 833
Mar 25, 2024 $0.780 $0.84 $0.775 $0.80 759 565
Mar 22, 2024 $0.741 $0.790 $0.725 $0.788 697 653
Mar 21, 2024 $0.779 $0.779 $0.744 $0.750 539 439
Mar 20, 2024 $0.732 $0.780 $0.730 $0.776 447 177
Mar 19, 2024 $0.740 $0.752 $0.720 $0.743 418 421
Mar 18, 2024 $0.720 $0.800 $0.700 $0.720 1 081 833
Mar 15, 2024 $0.683 $0.740 $0.683 $0.736 1 490 484
Mar 14, 2024 $0.716 $0.730 $0.681 $0.689 533 179
Mar 13, 2024 $0.718 $0.731 $0.710 $0.720 376 503
Mar 12, 2024 $0.720 $0.738 $0.650 $0.694 869 743
Mar 11, 2024 $0.730 $0.748 $0.720 $0.720 296 657
Mar 08, 2024 $0.740 $0.780 $0.730 $0.747 431 952
Mar 07, 2024 $0.720 $0.750 $0.715 $0.746 308 541
Mar 06, 2024 $0.730 $0.765 $0.702 $0.715 508 731
Mar 05, 2024 $0.750 $0.780 $0.730 $0.731 548 445
Mar 04, 2024 $0.774 $0.800 $0.760 $0.766 306 748
Mar 01, 2024 $0.756 $0.797 $0.756 $0.777 310 783
Feb 29, 2024 $0.80 $0.82 $0.761 $0.768 438 322
Feb 28, 2024 $0.749 $0.796 $0.749 $0.786 419 063
Feb 27, 2024 $0.740 $0.764 $0.740 $0.753 411 167
Feb 26, 2024 $0.755 $0.796 $0.740 $0.741 528 910
Feb 23, 2024 $0.770 $0.789 $0.760 $0.760 369 722
Feb 22, 2024 $0.766 $0.798 $0.761 $0.790 377 010
Click to get the best stock tips daily for free!

About Citius Pharmaceuticals Inc

Citius Pharmaceuticals Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected c... CTXR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT